Effects of enamel matrix derivative on proliferation/viability, migration, and expression of angiogenic factor and adhesion molecules in endothelial cells in vitro

Journal of Periodontology

Volumn 80, Issue 10, 2009, Pages 1622-1630

  Bertl, Kristina ^a   An, Na ^b   Bruckmann, Corinna ^a   Dard, Michel ^c   Andrukhov, Oleh ^a   Matejka, Michael ^a   Rausch Fan, Xiaohui ^a  

^a Bernhard Gottlieb University Clinic of Dentistry   (Austria)

^b PEKING UNIVERSITY SCHOOL AND HOSPITAL OF STOMATOLOGY   (China)

^c INSTITUT STRAUMANN AG   (Switzerland)

Author keywords

Angiogenesis; Enamel matrix proteins; Endothelial cells; Wound healing

Indexed keywords

ANGIOGENIC FACTOR; ANGIOPOIETIN 2; COLORING AGENT; DIAGNOSTIC AGENT; ENAMEL MATRIX PROTEINS; ENAMEL PROTEIN; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 1; TETRAZOLIUM; THIAZOLE DERIVATIVE; THIAZOLYL BLUE; TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; CELL COUNT; CELL CULTURE; CELL LINE; CELL MOTION; CELL PROLIFERATION; CELL SURVIVAL; CULTURE MEDIUM; CYTOLOGY; DRUG EFFECT; ENDOTHELIUM CELL; HUMAN; TIME; UMBILICAL VEIN; VASCULAR ENDOTHELIUM;

ANGIOGENESIS INDUCING AGENTS; ANGIOPOIETIN-2; CELL COUNT; CELL LINE; CELL MOVEMENT; CELL PROLIFERATION; CELL SURVIVAL; CELLS, CULTURED; COLORING AGENTS; CULTURE MEDIA, CONDITIONED; CULTURE MEDIA, SERUM-FREE; DENTAL ENAMEL PROTEINS; E-SELECTIN; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; TETRAZOLIUM SALTS; THIAZOLES; TIME FACTORS; TRANSFORMING GROWTH FACTOR BETA1; UMBILICAL VEINS;

EID: 70349684851     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.2009.090157     Document Type: Article

References (42)

1. Hammarstrom L. Enamel matrix, cementum development and regeneration. J Clin Periodontol 1997;24: 658-668.
2. Venezia E, Goldstein M, Boyan BD, Schwartz Z. The use of enamel matrix derivative in the treatment of periodontal defects: A literature review and metaanalysis. Crit Rev Oral Biol Med 2004;15:382-402.
3. Heden G, Wennström J, Lindhe J. Periodontal tissue alterations following Emdogain treatment of periodontal sites with angular bone defects. A series of case reports. J Clin Periodontol 1999;26:855-860.
4. Pilloni A, Paolantonio M, Camargo PM. Root coverage with a coronally positioned flap used in combination with enamel matrix derivative: 18-month clinical evaluation. J Periodontol 2006;77:2031-2039.
5. Sculean A, Windisch P, Keglevich T, Fabi B, Lundgren E, Lyngstadaas PS. Presence of an enamel matrix protein derivative on human teeth following periodontal surgery. Clin Oral Investig 2002;6:183-187.
6. Yukna RA, Mellonig JT. Histologic evaluation of periodontal healing in humans following regenerative therapy with enamel matrix derivative. A 10-case series. J Periodontol 2000;71:752-759.
7. Martin P. Wound healing - Aiming for perfect skin regeneration. Science 1997;276:75-81.
8. Distler JH, Hirth A, Kurowska-Stolarska M, Gay RE, Gay S, Distler O. Angiogenic and angiostatic factors in the molecular control of angiogenesis. Q J Nucl Med 2003;47:149-161.
9. Gharaee-Kermani M, Phan SH. Role of cytokines and cytokine therapy in wound healing and fibrotic diseases. Curr Pharm Des 2001;7:1083-1103.
10. Pepper MS. Transforming growth factor-beta: Vasculogenesis, angiogenesis, and vessel wall integrity. Cytokine Growth Factor Rev 1997;8:21-43.
11. Ferrari G, Pintucci G, Seghezzi G, Hyman K, Galloway AC, Mignatti P. VEGF, a prosurvival factor, acts in concert with TGF-beta1 to induce endothelial cell apoptosis. Proc Natl Acad Sci USA 2006;103:17260-17265.
12. Albelda SM, Smith CW, Ward PA. Adhesion molecules and inflammatory injury. FASEB J 1994;8:504-512.
13. Wennström JL, Lindhe J. Some effects of enamel matrix proteins on wound healing in the dento-gingival region. J Clin Periodontol 2002;29:9-14.
14. Hagenaars S, Louwerse PH, Timmerman MF, Van der Velden U, Van der Weijden GA. Soft-tissue wound healing following periodontal surgery and Emdogain application. J Clin Periodontol 2004;31: 850-856.
15. Gestrelius S, Andersson C, Lidstrom D, Hammarstrom L, Somerman M. In vitro studies on periodontal ligament cells and enamel matrix derivative. J Clin Periodontol 1997;24:685-692.
16. Bosshardt DD. Biological mediators and periodontal regeneration: A review of enamel matrix proteins at the cellular and molecular levels. J Clin Periodontol 2008;35(Suppl. 8)87-105.
17. Mirastschijski U, Konrad D, Lundberg E, Lyngstadaas SP, Jorgensen LN, Agren MS. Effects of a topical enamel matrix derivative on skin wound healing. Wound Repair Regen 2004;12:100-108.
18. Yuan K, Chen CL, Lin MT. Enamel matrix derivative exhibits angiogenic effect in vitro and in a murine model. J Clin Periodontol 2003;30:732-738.
19. Schlueter SR, Carnes DL, Cochran DL. In vitro effects of enamel matrix derivative on microvascular cells. J Periodontol 2007;78:141-151.
20. Johnson DL, Carnes D, Steffensen B, Cochran DL. Cellular effects of enamel matrix derivative areassociated with different molecular weight fractions following separation by size-exclusion chromatography. J Periodontol 2009;80:648-656.
21. Mosmann T. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J Immunol Methods 1983;65: 55-63.
22. James Kirkpatrick C, Fuchs S, Iris Hermanns M, Peters K, Unger RE. Cell culture models of higher complexity in tissue engineering and regenerative medicine. Biomaterials 2007;28:5193-5198.
23. Lamalice L, Le Boeuf F, Huot J. Endothelial cell migration during angiogenesis. Circ Res 2007;100:782-794.
24. Madri JA, Pratt BM, Tucker AM. Phenotypic modulation of endothelial cells by transforming growth factor-beta depends upon the composition and organization of the extracellular matrix. J Cell Biol 1988;106:1375-1384.
25. Jennings JC, Mohan S, Linkhart TA, Widstrom R, Baylink DJ. Comparison of the biological actions of TGF beta-1 and TGF beta-2: Differential activity in endothelial cells. J Cell Physiol 1988;137:167-172.
26. Müller G, Behrens J, Nussbaumer U, Böhlen P, Birchmeier W. Inhibitory action of transforming growth factor beta on endothelial cells. Proc Natl Acad Sci USA 1987;84:5600-5604.
27. Frater-Schroder M, Risau W, Hallmann R, Gautschi P, Böhlen P. Tumor necrosis factor type alpha, a potent inhibitor of endothelial cell growth in vitro, is angiogenic in vivo. Proc Natl Acad Sci USA 1987;84:5277-5281.
28. Leibovich SJ, Polverini PJ, Shepard HM, Wiseman DM, Shively V, Nuseir N. Macrophage-induced angiogenesis is mediated by tumour necrosis factor-alpha. Nature 1987;329:630-632.
29. Kahler CM, Kirchmair R, Kaufmann G, et al. Inhibition of proliferation and stimulation of migration of endothelial cells by secretoneurin in vitro. Arterioscler Thromb Vasc Biol 1997;17:932-939.
30. Fiedler U, Reiss Y, Scharpfenecker M, et al. Angiopoietin- 2 sensitizes endothelial cells to TNF-alpha and has a crucial role in the induction of inflammation. Nat Med 2006;12:235-239.
31. Hoang AM, Klebe RJ, Steffensen B, Ryu OH, Simmer JP, Cochran DL. Amelogenin is a cell adhesion protein. J Dent Res 2002;81:497-500.
32. Maycock J, Wood SR, Brookes SJ, Shore RC, Robinson C, Kirkham J. Characterization of a porcine amelogenin preparation, EMDOGAIN, a biological treatment for periodontal disease. Connect Tissue Res 2002;43: 472-476.
33. Mumulidu A, Hildebrand B, Fabi B, et al. Purification and analysis of a 5kDa component of enamel matrix derivative. J Chromatogr B Analyt Technol Biomed Life Sci 2007;857:210-218.
34. Veis A. Amelogenin gene splice products: Potential signaling molecules. Cell Mol Life Sci 2003;60:38-55.
35. Kawase T, Okuda K, Momose M, Kato Y, Yoshie H, Burns DM. Enamel matrix derivative (EMDOGAIN) rapidly stimulates phosphorylation of the MAP kinase family and nuclear accumulation of smad2 in both oral epithelial and fibroblastic human cells. J Periodontal Res 2001;36:367-376.
36. Kawase T, Okuda K, Yoshie H, Burns DM. Anti-TGFbeta antibody blocks enamel matrix derivative-induced upregulation of p21WAF1/cip1 and prevents its inhibition of human oral epithelial cell proliferation. J Periodontal Res 2002;37:255-262.
37. Wada Y, Yamamoto H, Nanbu S, Mizuno M, Tamura M. The suppressive effect of enamel matrix derivative on osteocalcin gene expression of osteoblasts is neutralized by an antibody against TGF-beta. J Periodontol 2008;79:341-347.
38. Hama H, Azuma H, Seto H, Kido J, Nagata T. Inhibitory effect of enamel matrix derivative on osteoblastic differentiation of rat calvaria cells in culture. J Periodontal Res 2008;43:179-185.
39. Lyngstadaas SP, Lundberg E, Ekdahl H, Andersson C, Gestrelius S. Autocrine growth factors in human periodontal ligament cells cultured on enamel matrix derivative. J Clin Periodontol 2001;28:181-188.
40. Hayashi M, Matsuzaki Y, Shimonaka M. Impact of plasminogen on an in vitro wound healing model based on a perfusion cell culture system. Mol Cell Biochem 2009;322:1-13.
41. Geer DJ, Swartz DD, Andreadis ST. Fibrin promotes migration in a three-dimensional in vitro model of wound regeneration. Tissue Eng 2002;8:787-798.
42. Thompson HG, Truong DT, Griffith CK, George SC. A three-dimensional in vitro model of angiogenesis in the airway mucosa. Pulm Pharmacol Ther 2007;20: 141-148.